整形手術用再生医療製品の世界市場：現状分析・予測（2022年～2028年）

世界の整形手術用再生医療製品の市場規模は、2021年～2027年の予測期間中にCAGRで約4%の成長が予測されています。

技術進歩の高まりと、手術製品の研究開発活動の増加により、世界市場の拡大が予想されます。その他の要因として、世界の肥満人口の増加が挙げられます。さらに、外傷の修復、整形手術の疼痛管理、関節再建、軟骨・腱の修復などの増加や、関節炎や骨粗しょう症などの整形手術問題の発生率の上昇が、市場を今後数年間牽引すると予想されます。

当レポートでは、世界の整形手術用再生医療製品市場について調査し、市場要約、市場の収益、製品・用途・エンドユーザー・地域別の市場洞察、市場力学、機会、企業プロファイル等に関する情報を提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法・前提条件

• 整形手術用再生医療製品市場の調査プロセス
• 整形手術用再生医療製品市場の調査手法
• 回答者プロファイル

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 世界の整形手術用再生医療製品市場におけるCOVID-19の影響

第6章 世界の整形手術用再生医療製品市場の収益、2019年～2027年F

第7章 市場洞察：製品別

• 同種移植片
• 合成
• 細胞ベース
• 粘性サプリメント

第8章 市場洞察：用途別

• 整形手術の疼痛管理
• 外傷の修復
• 軟骨・腱の修復
• 関節再建
• その他

第9章 市場洞察：エンドユーザー別

• 病院
• 外来手術センター
• その他

第10章 市場洞察：地域別

• 北米市場
  • 米国
  • カナダ
  • その他の北米
• 欧州市場
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋市場
  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他のアジア太平洋
• その他の地域市場

第11章 整形手術用再生医療製品市場：市場力学

• 市場促進要因
• 市場課題
• 影響分析

第12章 整形手術用再生医療製品市場：機会

第13章 整形手術用再生医療製品市場：動向

第14章 法律・規制の枠組み

第15章 需要サイド・供給サイド分析

• 需要サイド分析
• 供給サイド分析

第16章 バリューチェーン分析

第17章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第18章 企業プロファイル

• Anika Therapeutics, Inc.
• Vericel Corporation
• Baxter
• Zimmer Biomet
• Stryker
• Smith & Nephew
• AlloSource
• Amniox Medical, Inc.
• VSY Biotechnology
• Aptissen S.A.

第19章 免責事項

The orthopedic regenerative surgical products market is expected to register a CAGR of approx. 4% over the period of 2021-2027. Regenerative orthopedics help treat discomfort and pain in the musculoskeletal system and improve the healing of orthopedic conditions, such as ligaments, tendon injuries, muscles, bones, knee meniscus, intervertebral discs life, and cartilage. These parts of the body have a relatively low capacity for self-healing. Regenerative orthopedic surgical products help these tissues heal faster. Orthopedic regenerative surgical products can help some patients avoid orthopedic surgery altogether. The global orthopedic regenerative surgical products market is anticipated to witness an uptick with the growing technological advancement and increased research and development activities for the surgical product. Some other factors which drive the market include the rise in the obese population across the globe. In 2020, according to Trust For America's Health, the U.S. adult obesity rate stands at 42.4 percent, the first time the national rate has passed the 40 percent mark, and further evidence of the country's obesity crisis. Owing to these glaring statistics the demand for orthopedic regenerative surgical products is anticipated to grow in the forthcoming years because obesity causes an alteration of bone-regulating hormones, increased oxidative stress and inflammation, and altered bone cell metabolism which damages the bone internally. Furthermore, the increase in the number of trauma repair, orthopedic pain management, joint reconstruction, and cartilage and tendon repair as well as the rising incidences of orthopedic problems such as arthritis and osteoporosis, are expected to drive the market for orthopedic regenerative surgical products market in the coming years.

Some of the major factors such as obesity coupled with the growing healthcare expenditure are propelling the growth of this market in the region. Moreover, an increase in road accident cases also propels the growth of the market. For instance, according to the studies in 2020, One of the factors causing bone fractures is Road Traffic Accidents (RTAs), which are the first leading cause of death among people aged 15-29 years. In 2019, the global number of new cases of fracture was estimated to be 178 million (95%), an increase of 33*4% since 1990. Furthermore, the increasing prevalence of joint reconstruction, growing health care expenditure, and awareness among patients and healthcare are significantly growing the orthopedic regenerative surgical products market.

Anika Therapeutics, Inc., Vericel Corporation, Baxter, Zimmer Biomet, Stryker, Smith & Nephew, AlloSource, Amniox Medical, Inc., VSY Biotechnology, Aptissen S.A. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst Product, the viscosupplements category accounted for the majority share in the market in 2020"

Based on product, the market is classified into allografts, synthetic, cell-based, and viscosupplements. Amongst these, the viscosupplement category accounted for a significant share of the market owing to the rising incidence of knee pain, osteoarthritis, and related symptoms and an increase in product availability driving the growth of this segment. Moreover, factors such as aging, obesity, excessive exercise, external injury, and genetic predisposition, further contribute to knee osteoarthritis, thus driving the market for orthopedic regenerative surgical products

"Among Applications, the joint reconstruction is expected to witness highest CAGR during the forecast period"

Based on application, the market is categorized into knee surgeries, hip surgeries, spine surgeries, and others. Among these, knee surgeries are expected to witness the highest CAGR during the forecast period. increasing surgical procedures, geriatric patients, and the incidence of trauma cases are likely to aid the segment's growth. In addition, increased adoption of regenerative solutions in joint reconstruction, and technological advancements also boost the segment of the market growth.

"Among End-Users, the Hospitals is expected to witness highest CAGR during the forecast period"

Based on end-users, the market is categorized into hospitals, ambulatory surgical centers, and others. Among these, the hospitals are expected to witness the highest CAGR during the forecast period. The hospital offers a wide range of treatment options in terms of pain management and orthopedic surgery. Furthermore, the factors contributing to the large share of the segment include a higher volume of orthopedic procedures performed in hospital settings.

"North America to witness significant growth during the forecast period"

For a better understanding of the market dynamics of the orthopedic regenerative surgical products market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the orthopedic regenerative surgical products market industry and generated revenue owing to the presence of well-established market players and technologically advanced healthcare facilities in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global orthopedic regenerative surgical products market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stake Holders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Orthopedic Regenerative Surgical Products Market
• 2.2. Research Methodology of the Orthopedic Regenerative Surgical Products Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET COVID-19 IMPACT

6 GLOBAL ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

• 7.1. Allografts
• 7.2. Synthetic
• 7.3. Cell-Based
• 7.4. Viscosupplements

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Orthopedic Pain Management
• 8.2. Trauma Repair
• 8.3. Cartilage and Tendon Repair
• 8.4. Joint Reconstruction
• 8.5. Others

9 MARKET INSIGHTS BY END-USERS

• 9.1. Hospitals
• 9.2. Ambulatory Surgical Centers
• 9.3. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America Orthopedic Regenerative Surgical Products Market
  • 10.1.1. United States
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe Orthopedic Regenerative Surgical Products Market
  • 10.2.1. Germany
  • 10.2.2. France
  • 10.2.3. United Kingdom
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia Pacific Orthopedic Regenerative Surgical Products Market
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Australia
  • 10.3.5. Rest of Asia Pacific
• 10.4. Rest of World Orthopedic Regenerative Surgical Products Market Rest of Asia Pacific

11 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET DYNAMICS REST OF THE WORLD ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET OPPORTUNITIES

13 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

• 18.1. Anika Therapeutics, Inc.
• 18.2. Vericel Corporation
• 18.3. Baxter
• 18.4. Zimmer Biomet
• 18.5. Stryker
• 18.6. Smith & Nephew
• 18.7. AlloSource
• 18.8. Amniox Medical, Inc.
• 18.9. VSY Biotechnology
• 18.10. Aptissen S.A.

19 DISCLAIMER